Ryman Healthcare Ltd (ASX: RYM) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Ryman Healthcare Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Ryman Healthcare Ltd (ASX: RYM)
Latest News
Share Gainers
Why BHP, BlueScope, Catalyst Metals, and Ryman shares are storming higher today
RYM ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Ryman Healthcare Ltd
Ryman Healthcare Ltd develops, owns, and operates retirement villages and aged-care facilities in New Zealand and Australia. Its villages offer a combination of independent and serviced units, alongside hospital, dementia, and rest-home care. Income is predominantly earned from aged care fees, retirement unit management fees, development margins on new units, and capital gains generated when residents vacate and Ryman resells existing units.
RYM Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 24 Feb 2026 | $2.01 | $-0.04 | -1.95% | 1,740 | $2.09 | $2.09 | $2.01 |
| 23 Feb 2026 | $2.05 | $-0.17 | -7.66% | 6,132 | $2.08 | $2.14 | $2.05 |
| 20 Feb 2026 | $2.22 | $0.08 | 3.74% | 1,705 | $2.13 | $2.22 | $2.13 |
| 19 Feb 2026 | $2.14 | $0.01 | 0.47% | 2 | $2.14 | $2.14 | $2.14 |
| 18 Feb 2026 | $2.13 | $-0.04 | -1.84% | 291 | $2.12 | $2.13 | $2.12 |
| 17 Feb 2026 | $2.17 | $0.07 | 3.33% | 1,576 | $2.12 | $2.17 | $2.11 |
| 16 Feb 2026 | $2.10 | $-0.13 | -5.83% | 22,355 | $2.23 | $2.23 | $2.10 |
| 13 Feb 2026 | $2.23 | $-0.06 | -2.62% | 5,923 | $2.37 | $2.37 | $2.23 |
| 12 Feb 2026 | $2.29 | $-0.07 | -2.97% | 7,096 | $2.34 | $2.35 | $2.27 |
| 11 Feb 2026 | $2.36 | $0.02 | 0.85% | 4,727 | $2.36 | $2.36 | $2.31 |
| 10 Feb 2026 | $2.34 | $-0.05 | -2.09% | 15,934 | $2.35 | $2.37 | $2.34 |
| 09 Feb 2026 | $2.39 | $0.14 | 6.22% | 443 | $2.36 | $2.39 | $2.36 |
| 06 Feb 2026 | $2.25 | $-0.10 | -4.26% | 8,943 | $2.38 | $2.41 | $2.25 |
| 05 Feb 2026 | $2.35 | $-0.02 | -0.84% | 25,816 | $2.32 | $2.43 | $2.32 |
| 04 Feb 2026 | $2.37 | $-0.02 | -0.84% | 21,924 | $2.33 | $2.37 | $2.25 |
| 03 Feb 2026 | $2.39 | $-0.05 | -2.05% | 8,205 | $2.43 | $2.44 | $2.39 |
| 02 Feb 2026 | $2.44 | $0.04 | 1.67% | 2,483 | $2.42 | $2.44 | $2.42 |
| 30 Jan 2026 | $2.40 | $-0.06 | -2.44% | 21,863 | $2.45 | $2.45 | $2.40 |
| 29 Jan 2026 | $2.46 | $-0.01 | -0.40% | 3,896 | $2.46 | $2.49 | $2.46 |
| 28 Jan 2026 | $2.47 | $-0.05 | -1.98% | 10,471 | $2.54 | $2.54 | $2.47 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 15 Dec 2025 | Dean Hamilton | Buy | 7,253 | $21,323 |
On-market trade. As per announcement 16-12-25
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr James Bruce Miller | Non-Executive Director |
Mr Miller has knowledge in both audit and risk and financial markets and is the Chair of Channel Infrastructure and a director of Mercury NZ, Vista Group, and Fletcher Building. James was also previously Chair of NZX. He is also a chair of Finance, Risk committee, and member of Governance committee.
|
|
| Ms Paula Jeffs | Non-Executive Director |
Ms Jeffs is an executive, currently holding the position of Executive General Manager People and Transformation at Melbourne Water. She brings more than 25 years experience culture, capability and safety in organisations across the healthcare and finance sectors. Early in her working life, Paula spent several years as a carer in the aged and disability sector . She is also a chair of of People, Safety committee and member of Clinical Governance committee.
|
|
| Mr David Pitman | Non-Executive Director |
Mr Pitman has over 35 years experience in general, operational and financial management, strategy development and M&A. As a Group Executive at Stockland for more than six years, he led Group Strategy and was the CEO of Stockland Retirement Living. He is a former partner with Boston Consulting Group and serves as the firms Global Finance Director, based in Boston. He is also a member of Finance, Risk committee
|
|
| Ms Kathryn(Kate) Marian Munnings | Non-Executive Director |
Ms Munnings is the Managing Director of Vitrafy Life Sciences Ltd. Kates previous roles include Managing Director and Chief Executive Officer of Virtus Health Limited and Chief Operating Officer of Ramsay Health Care. Kate has experience across the construction, law and healthcare sectors. She is a former partner at law firm Baker Mackenzie and is currently the Chair of Digital Health CRC in Australia and a non-executive director at Wesfarmers Limited. She is also a member of People, Safety committee and chair of Clinical committee.
|
|
| Mr Scott Pritchard | Non-Executive Director |
Mr Pritchard has been CEO of Precinct Properties, New Zealands owner, developer, and manager of premium real estate in Auckland and Wellington, since 2010. Scott has experience in property development, property funds management and asset management. Scott also serves as the Independent Chair of the Auckland Council City Centre Advisory Panel and is a Trustee of the Tania Dalton Foundation. Scott was previously a Board member of Property Council New Zealand for 14 years and Chair for four of those years He is also a member of People, Safety committee committee.
|
|
| Mr Dean Ross Hamilton | Non-Executive ChairmanNon-Executive Director |
Mr Hamilton has background in governance, company leadership and financial markets across New Zealand and Australia. He is currently Chair of Fulton Hogan and holds director roles at Auckland International Airport and The Warehouse Group. He is also a member of Finance, Risk committee, People, Safety committee and Governance committee.
|
|
| Ms Naomi James | Chief Executive Officer |
-
|
|
| Mr Morgan Powell | Company Secretary |
-
|
|
| Naomi James | Chief Executive Officer |
-
|
|
| Morgan Powell | Company Secretary |
-
|